James Deardorff, MD
Assistant Professor
Medicine
School of Medicine

He received training in epidemiology and biostatistics through the 1-year Advanced Training in Clinical Research certificate program at UCSF.

Dr. Deardorff’s research interest involves improving clinical care and decision making for medically complex older adults at critical transition points in their lives, such as a skilled nursing facility admission. He has completed two projects focused on the development of clinical prediction models to predict mortality risk and need for nursing home level of care among persons with dementia.

In his clinical work, Dr. Deardorff provides care for individuals at the Jewish Home skilled nursing facility and in the hospital on the geriatrics-orthopedic surgery co-management service and general geriatrics consult service.

• Incorporating Prognosis into Clinical Decision-Making for Older Adults with Diabetes.
  Journal of general internal medicine 2023 Deardorff WJ, Covinsky K
• Medication misuse and overuse in community-dwelling persons with dementia.
  Journal of the American Geriatrics Society 2023 Deardorff WJ, Jing B, Growdon ME, Yaffe K, Boscardin WJ, Boockvar KS, Steinman MA
• Improving Clinical Applicability of Mortality Prediction Models Among Persons With Dementia-Reply.
  JAMA internal medicine 2023 Deardorff WJ, Smith AK, Lee SJ
• Fingerstick glucose monitoring by cognitive impairment status in Veterans Affairs nursing home residents with diabetes.
  Journal of the American Geriatrics Society 2022 Nguyen B, Deardorff WJ, Shi Y, Jing B, Lee AK, Lee SJ
• Do functional status and Medicare claims data improve the predictive accuracy of an electronic health record mortality index? Findings from a national Veterans Affairs cohort.
  BMC geriatrics 2022 Deardorff WJ, Jing B, Jeon SY, Boscardin WJ, Lee AK, Fung KZ, Lee SJ
• Comparing Machine Learning to Regression Methods for Mortality Prediction Using Veterans Affairs Electronic Health Record Clinical Data.
  Medical care 2022 Jing B, Boscardin WJ, Deardorff WJ, Jeon SY, Lee AK, Donovan AL, Lee SJ
• Mild cognitive impairment as a clinical and research outcome: Ready for prime time?
  Journal of the American Geriatrics Society 2022 Deardorff WJ, Lee SJ
• COVID-19, masks, and hearing difficulty: Perspectives of healthcare providers.
  Journal of the American Geriatrics Society 2021 Deardorff WJ, Binford SS, Cole I, James T, Rathfon M, Rennke S, Wallhagen M
• Hospitalization Risk Among Older Adults with Sensory Impairments: Development of a Prognostic Model.
  Journal of the American Geriatrics Society 2020 Deardorff WJ, Sloane RJ, Pavon JM, Hastings SN, Whitson HE
• Regulation of Iron Homeostasis through Parkin-Mediated Lactoferrin Ubiquitylation.
  Biochemistry 2020 Gholkar AA, Schmollinger S, Velasquez EF, Lo YC, Cohn W, Capri J, Dharmarajan H, Deardorff WJ, Gao LW, Abdusamad M, Whitelegge JP, Torres JZ
• Association of Sensory and Cognitive Impairment With Healthcare Utilization and Cost in Older Adults.
  Journal of the American Geriatrics Society 2019 Deardorff WJ, Liu PL, Sloane R, Van Houtven C, Pieper CF, Hastings SN, Cohen HJ, Whitson HE
• Behavioral and psychological symptoms in Alzheimer's dementia and vascular dementia.
  Handbook of clinical neurology 2019 Deardorff WJ, Grossberg GT
• A fixed-dose combination of memantine extended-release and donepezil in the treatment of moderate-to-severe Alzheimer's disease.
  Drug design, development and therapy 2016 Deardorff WJ, Grossberg GT
• Pharmacotherapeutic strategies in the treatment of severe Alzheimer's disease.
  Expert opinion on pharmacotherapy 2016 Deardorff WJ, Grossberg GT
• Targeting neuroinflammation in Alzheimer's disease: evidence for NSAIDs and novel therapeutics.
  Expert review of neurotherapeutics 2016 Deardorff WJ, Grossberg GT
• Efficacy of rivastigmine tartrate, transdermal system, in Alzheimer's disease.
  Expert opinion on pharmacotherapy 2016 Nieto RA, Deardorff WJ, Grossberg GT
• The Use of Cholinesterase Inhibitors Across All Stages of Alzheimer's Disease.
  Drugs & aging 2015 Deardorff WJ, Feen E, Grossberg GT
• Tctex1d2 associates with short-rib polydactyly syndrome proteins and is required for ciliogenesis.
  Cell cycle (Georgetown, Tex.) 2015 Gholkar AA, Senese S, Lo YC, Capri J, Deardorff WJ, Dharmarajan H, Contreras E, Hodara E, Whitelegge JP, Jackson PK, Torres JZ
• Safety and clinical effects of EVP-6124 in subjects with Alzheimer's disease currently or previously receiving an acetylcholinesterase inhibitor medication.
  Expert review of neurotherapeutics 2014 Deardorff WJ, Shobassy A, Grossberg GT
• A review of the clinical efficacy, safety and tolerability of the antidepressants vilazodone, levomilnacipran and vortioxetine.
  Expert opinion on pharmacotherapy 2014 Deardorff WJ, Grossberg GT